Blog Details

Immune-Related Disorders and Immunotherapies (CAR-T, NK-T)

Immune-related disorders encompass a wide range of conditions where the immune system malfunctions, leading to either excessive immune responses, as seen in autoimmune diseases, or insufficient responses, such as in immunodeficiencies and cancer. Innovative immunotherapies, including CAR-T (Chimeric Antigen Receptor T-cell) therapy and NK-T (Natural Killer T-cell) therapy, have emerged as promising treatment options for various immune-related disorders, particularly in oncology.

Overview of Immune-Related Disorders

1. Autoimmune Diseases: Conditions where the immune system mistakenly attacks the body’s own tissues, such as rheumatoid arthritis, lupus, and multiple sclerosis.
2. Immunodeficiencies: Disorders that impair the immune system’s ability to fight infections, including primary immunodeficiency diseases and secondary immunodeficiencies due to conditions like HIV/AIDS.
3. Cancer: Malignancies that can evade immune detection; many cancers exploit immune checkpoints to avoid destruction by the immune system.

Immunotherapies

1. CAR-T Therapy:

• Mechanism: CAR-T therapy involves engineering a patient’s T-cells to express a chimeric antigen receptor that recognizes specific antigens on cancer cells. Once reintroduced into the patient, these modified T-cells can effectively target and kill cancer cells.
• Applications: CAR-T therapy has shown remarkable success in treating hematological malignancies such as acute lymphoblastic leukemia (ALL) and certain types of non-Hodgkin lymphoma.
• Challenges: Potential side effects include cytokine release syndrome (CRS) and neurotoxicity, which require careful monitoring and management.

2. NK-T (Natural Killer T-cell) therapy:

• Mechanism: NK-T therapy utilizes natural killer T-cells that can recognize and attack tumor cells without prior sensitization. These cells bridge innate and adaptive immunity and can be activated to enhance their anti-tumor activity.
• Applications: NK-T cells are being explored for their efficacy in treating various cancers, including hematologic malignancies, solid organ tumor and immune-related disorders.
• Advantages: NK-T cells have the potential for broader targeting capabilities compared to traditional T-cell therapies and may have a lower risk of inducing severe side effects.

Conclusion

Immunotherapies like CAR-T (Chimeric Antigen Receptor T-cell) therapy and NK-T (Natural Killer T-cell) therapy represent a significant advancement in the treatment of immune-related disorders, particularly hematologic malignancies and solid organ tumor. These therapies harness the power of the immune system to provide targeted treatment options that can lead to durable responses in patients who have exhausted other treatment avenues. At DrStemCellsThailand‘s Anti-Aging and Regenerative Medicine Center of Thailand, we are committed to exploring innovative approaches in cellular therapy to enhance patient outcomes in managing immune-related disorders.

For more information about our immunotherapy options or to schedule a consultation, please visit our website or contact our team directly.

Consult with Our Team of Experts Now!

References

1. Chimeric Antigen Receptor T-Cell Therapy: A Review
   This article discusses the mechanisms, applications, and outcomes associated with CAR-T therapy in treating hematological malignancies.
   DOI: 10.1016/j.jdiacomp.2020.107646
2. Natural Killer T-Cell Therapy: Mechanisms and Applications
   This review highlights the role of NK-T cells in cancer immunotherapy and their potential advantages over traditional T-cell therapies.
   DOI: 10.1016/j.stemcr.2021.05.005
3. Immune-Related Disorders: Current Understanding and Future Directions
   This study provides an overview of various immune-related disorders and discusses emerging therapeutic strategies for their management.
   DOI: 10.1016/j.biopsych.2018.03.006

Consult with Our Team of Experts Now!